Wall Street analyst estimates for Calidi Biotherapeutics, Inc. (CLDI): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 0.53 |
| EV / EBITDA | 0.09 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | $449000 | $45000 | 0 | 0 | 0 |
| Cost of Revenue | 0 | $94000 | $274000 | $1.3M | 0 | $1.7M |
| Gross Profit | 0 | $355000 | -$229000 | -$1.3M | 0 | -$1.7M |
| Research & Development | $3.2M | $4.7M | $7.3M | $13.0M | $8.9M | $9.7M |
| Selling, General & Admin | $3.6M | $6.2M | $15.6M | $16.0M | $12.9M | $10.5M |
| Operating Expenses | $6.8M | $10.8M | $22.9M | $27.7M | $21.8M | $18.6M |
| Operating Income | -$6.8M | -$10.5M | -$23.1M | -$29.0M | -$21.8M | -$20.2M |
| EBITDA | -$6.7M | -$9.4M | -$25.0M | -$24.2M | -$19.7M | -$18.2M |
| Interest Expense | $163000 | $614000 | $158000 | $3.7M | $933000 | $207000 |
| Pre-tax Income | -$7.9M | $3.4M | -$25.4M | -$29.2M | -$22.2M | -$20.0M |
| Income Tax | $4000 | $11000 | $11000 | $16000 | $14000 | $15000 |
| Net Income | -$7.9M | -$10.9M | -$25.4M | -$29.2M | -$22.1M | -$19.9M |
| EPS | $-42.24 | $226.56 | $-5740.80 | $-3321.76 | $-571.20 | $-95.20 |
| EPS (Diluted) | $-42.24 | $226.56 | $-5740.80 | $-3321.76 | $-571.20 | $-95.20 |
| Shares Outstanding (Diluted) | $186265 | $14914 | $4412 | $8760 | $41526 | $268875 |
Price
| Price | $1.17 |
| Market Cap | $1M |
| Exchange | AMEX |
| Country | US |
Related companies: CANF · CMND · CNSP · KZIA · QLGN · SILO · SNGX
Explore sector: Healthcare · Biotechnology
More sections of CLDI: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks